Anixa Biosciences, Inc.
ANIX
$2.76
$0.031.10%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 210.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 0.00 | 210.00K |
| Cost of Revenue | -- | -- | 0.00 | 0.00 | 161.00K |
| Gross Profit | -- | -- | 0.00 | 0.00 | 49.00K |
| SG&A Expenses | 7.01M | 7.44M | 7.18M | 7.27M | 7.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.61M | 13.83M | 13.72M | 12.97M | 12.27M |
| Operating Income | -13.61M | -13.83M | -13.72M | -12.97M | -12.06M |
| Income Before Tax | -12.62M | -12.70M | -12.51M | -11.74M | -10.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.62 | -12.70 | -12.51 | -11.74 | -10.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 138.00K | 144.00K | 145.00K | 144.00K | 122.00K |
| Net Income | -12.48M | -12.55M | -12.36M | -11.60M | -10.74M |
| EBIT | -13.61M | -13.83M | -13.72M | -12.97M | -12.06M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.39 | -0.39 | -0.39 | -0.37 | -0.35 |
| Normalized Basic EPS | -0.24 | -0.24 | -0.24 | -0.23 | -0.21 |
| EPS Diluted | -0.39 | -0.39 | -0.39 | -0.37 | -0.35 |
| Normalized Diluted EPS | -0.24 | -0.24 | -0.24 | -0.23 | -0.21 |
| Average Basic Shares Outstanding | 128.35M | 127.59M | 126.51M | 125.43M | 124.45M |
| Average Diluted Shares Outstanding | 128.35M | 127.59M | 126.51M | 125.43M | 124.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
